Abstract
Ehlers-Danlos syndrome (EDS) is a group of clinically and genetically heterogeneous heritable connective tissue disorders (Yeowell and Pinnell 1993) affecting the skin, ligaments, joints, blood vessels, and internal organs. EDS is characterized by skin extensibility, joint hypermobility (JHM), and tissue fragility. EDS results from mutations in genes involved in extracellular matrix formation and organization, leading to a predisposition for loss of structural integrity in tissues within multiple organ systems (Barabas 1967). The prevalence of EDS is estimated to be about 1 in 5,000 births (Steinmann et al. 1993).
References
Abayazeed, A., Hyman, E., Moghadamfalahi, M., et al. (2014). Vascular type Ehlers-Danlos syndrome with fatal spontaneous rupture of a right common iliac artery dissection: Case report and review of literature. Radiology Case, 8, 63–69.
Barabas, A. P. (1967). Heterogeneity of the Ehlers-Danlos syndrome: Description of three clinical types and a hypothesis to explain the basic defects. British Medical Journal, 2, 612–613.
Beighton, P. (1992). The Ehlers-Danlos syndrome. In P. Beighton (Ed.), McKusick’s heritable disorders of connective tissue (pp. 189–251). St Louis: Mosby.
Beighton, P., & Curtis, D. (1985). X-linked Ehlers-Danlos syndrome type V: The next generation. Clinical Genetics, 27, 472–478.
Beighton, P., De Paepe, A., Steinmann, B., et al. (1998). Ehlers-Danlos syndromes: Revised nosology, Villefranche, 1997. American Journal of Medical Genetics, 77, 31–37.
Beridze, N., & Frishman, W. H. (2012). Vascular Ehlers-Danlos syndrome: Pathophysiology, diagnosis, and prevention and treatment of its complications. Cardiology in Review, 20, 4–7.
Brooke, B. S., Arnaoutakis, G., McDonnell, N. B., et al. (2010). Contemporary management of vascular complications associated with Ehlers-Danlos syndrome. Journal of Vascular Surgery, 51, 131–139.
Byers, P. H. (1995). Ehlers-Danlos syndrome type IV: A genetic disorder in many guises. The Journal of Investigative Dermatology, 105, 311–313.
Byers, P. H. (2001). An exception to the rule. The New England Journal of Medicine, 345, 1203–1204.
Byers, P. H., & Murray, M. L. (2014). Ehlers–Danlos syndrome: A showcase of conditions that lead to understanding matrix biology. Matrix Biology, 33, 10–15.
Byers, P. H., Duvic, M., Atkinson, M., et al. (1997). Ehlers-Danlos syndrome type VIIA and VIIB result from splice-junction mutations or genomic deletions that involve exon 6 in the COL1A1 and COL1A2 genes of type I collagen. American Journal of Medical Genetics, 72, 94–105.
Castori, M., Camerota, F., Celletti, C., et al. (2010). Natural history and manifestations of the hypermobility type Ehlers-Danlos syndrome: A pilot study on 21 patients. American Journal of Medical Genetics Part A, 152A, 556–564.
Colombi, M., Dordoni, C., Chiarelli, N., et al. (2015). Differential diagnosis and diagnostic flow chart of joint hypermobility syndrome/Ehlers–Danlos syndrome hypermobility type compared to other heritable connective tissue disorders. American Journal of Medical Genetics Part C, 169C, 6–22.
De Paepe, A., Nuytinck, L., Hausser, I., et al. (1997). Mutations in the COL5A1 gene are causal in the Ehlers-Danlos syndromes I and II. American Journal of Human Genetics, 60, 547–554.
Giunta, C., Superti-Furga, A., Spranger, S., et al. (1999). Ehlers-Danlos syndrome type VII: Clinical features and molecular defects. Journal of Bone and Joint Surgery (British), 81, 225–238.
Levy, H. P. (2016). Ehlers-Danlos syndrome, hypermobility type. GeneReviews. Updated 31 Mar 2016. Available at http://www.ncbi.nlm.nih.gov/books/NBK1279/
Malfait, F., & De Paepe, A. (2014). The Ehlers-Danlos syndrome. Advances in Experimental Medicine and Biology, 802, 129–143.
Malfait, F., Wenstrup, R., & De Paepe, A. (2011). Ehlers-Danlos syndrome, classic type. GeneReviews. Retrieved 18 Aug 2011. Available at http://www.ncbi.nlm.nih.gov/books/NBK1244/
Mao, J. R., & Bristow, J. (2001). The Ehlers-Danlos syndrome: On beyond collagens. The Journal of Clinical Investigation, 107, 1063–1069.
McKusick, V. A. (1972). Heritable disorders of connective tissue. Saint Louis: CV Mosby.
Mentzel, H. J., Seidel, J., Vogt, S., et al. (1999). Vascular complications (splenic and hepatic artery aneurysms) in the occipital horn syndrome: Report of a patient and review of the literature. Pediatric Radiology, 29, 19–22.
Michalickova, K., Susic, M., Willing, M. C., et al. (1998). Mutations of the alpha2(V) chain of type V collagen impair matrix assembly and produce Ehlers-Danlos syndrome type I. Human Molecular Genetics, 7, 249–255.
Nuytinck, L., Freund, M., Lagae, L., et al. (2000). Classical Ehlers-Danlos syndrome caused by a mutation in type I collagen. American Journal of Human Genetics, 66, 1398–1402.
Pepin, M. G., Murray, M. L., & Byers, P. H. (2015). Ehlers-Danlos syndrome, type IV. GeneReviews. Retrieved 19 Nov 2015. Available at http://www.ncbi.nlm.nih.gov/books/NBK1494/
Pope, F. M., & Burrow, N. P. (1997). Ehlers-Danlos syndrome has varied molecular mechanisms. Journal of Medical Genetics, 34, 400–410.
Pyeritz, R. E. (2000). Ehlers-Danlos syndrome. The New England Journal of Medicine, 342, 730–732.
Schalkwijk, J., Zweers, M. C., Steijlen, P. M., et al. (2001). A recessive form of the Ehlers-Danlos syndrome caused by tenascin-X deficiency. The New England Journal of Medicine, 345, 1167–1175.
Smith, L. T., Wertelecki, W., Milstone, L. M., et al. (1992). Human dermatosparaxis: A form of Ehlers-Danlos syndrome that results from failure to remove the aminoterminal propeptide of type I procollagen. American Journal of Human Genetics, 51, 235–244.
Steinmann, B., Royce, P. M., & Superti-Furga, A. (1993). The Ehlers-Danlos syndrome. In P. M. Royce & B. Steinmkann (Eds.), Connective tissue and its heritable disorders. Molecular, genetic, and medical aspects (pp. 351–408). New York: Wiley-Liss.
Tiller, G. E., Cassidy, S. B., Wensel, C., et al. (1998). Aortic root dilatation in Ehlers-Danlos syndrome types I, II and III. A report of five cases. Clinical Genetics, 53, 460–465.
Wenstrup, R. J., Florer, J. B., Willing, M. C., et al. (2000). COL5A1 Haploinsufficiency is a common molecular mechanism underlying the classical form of EDS. American Journal of Human Genetics, 66, 1766–1776.
Yeowell, H. N., & Pinnell, S. R. (1993). The Ehlers-Danlos syndromes. Seminars in Dermatology, 12, 229–240.
Yeowell, H. N., & Steinmann, B. (2013). Ehlers-Danlos syndrome, kyphoscoliotic form. GeneReviews. Updated 24 Jan 2013. Available at http://www.ncbi.nlm.nih.gov/books/NBK1462/
Yeowell, H. N., & Walker, L. C. (2000). Mutations in the lysyl hydroxylase 1 gene that result in enzyme deficiency and the clinical phenotype of Ehlers-Danlos syndrome type VI. Molecular Genetics and Metabolism, 71, 212–224.
Zweers, M. C., Bristow, J., Steijlen, P. M., et al. (2003). Haploinsufficiency of TNXB is associated with hypermobility type of Ehlers-Danlos syndrome. American Journal of Human Genetics, 73, 214–217.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2016 Springer Science+Business Media New York
About this entry
Cite this entry
Chen, H. (2016). Ehlers-Danlos Syndrome. In: Atlas of Genetic Diagnosis and Counseling. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-6430-3_78-2
Download citation
DOI: https://doi.org/10.1007/978-1-4614-6430-3_78-2
Received:
Accepted:
Published:
Publisher Name: Springer, New York, NY
Online ISBN: 978-1-4614-6430-3
eBook Packages: Springer Reference Biomedicine and Life SciencesReference Module Biomedical and Life Sciences